Home / Pharmaceutical company intelligence
Mediate Pharmaceutical Pvt Ltd logo
Pharmaceutical company intelligence

Mediate Pharmaceutical products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer with formulation, R&D, quality and regulatory capabilities across a broad product portfolio.

Mediate Pharmaceutical products in Pakistan

Mediate Pharmaceutical Pvt Ltd has 236 medicine presentations registered in Pakistan under 111 brands, covering 89 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Cardiovascular. Its brands with the most registered strengths and packs are Epimed (Sodium valproate, Valproic acid), Tricetam (Levetiracetam), C-Prox (Ciprofloxacin) and Cefafin (Ceftriaxone). 236 products have an official DRAP price on MedInfoBase. See all 111 brands A to Z

Database-driven profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public source rechecked
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jan 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 18 Oct 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public source rechecked
Legal / official name
Mediate Pharmaceutical (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot 148-151, Sector 24, Korangi Industrial Area, Karachi, Pakistan
Phone
+92 21 35074746-7
Official contact
Contact page ↗
Corporate source details checked
18 Oct 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000167 Mediate Pharmaceutical (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000167 238 linked products · source seen 13 Nov 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗ Logo Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx261public portfolio records represented
REG213unique registrations represented
IDX19indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER108registry-verified exact registrations
PKR236current validated price records
G89generic molecules in indexed catalogue
DF8dosage-form groups
TA13therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage89%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMediate Pharmaceutical Pvt LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/mediate-pharmaceutical-pvt-ltdGenerated 13 Nov 2026Anti-infectives97 · 41%CNS & mental health36 · 15%Cardiovascular34 · 14%Oncology & immunology13 · 6%Respiratory & allergy11 · 5%Gastrointestinal & hepatology10 · 4%Vitamins, minerals & nutrition10 · 4%Other therapeutic areas25 · 11%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMediate Pharmaceutical Pvt LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/mediate-pharmaceutical-pvt-ltdGenerated 13 Nov 2026236presentationsTablet118 · 50%Injection45 · 19%Capsule33 · 14%Suspension24 · 10%Solution5 · 2%Syrup5 · 2%Other forms6 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMediate Pharmaceutical Pvt LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/mediate-pharmaceutical-pvt-ltdGenerated 13 Nov 2026209comparable productsBelow peer median159 · 76%Near peer median28 · 13%Above peer median22 · 11%Company median price position-13.2%Lowest-price equivalents51Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMediate Pharmaceutical Pvt LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/mediate-pharmaceutical-pvt-ltdGenerated 13 Nov 2026Nabiqasim Industries (Pvt) Ltd.,47 shared53% overlapNeutro Pharma (Pvt.) Ltd.,46 shared52% overlapPharmasol (Pvt) Ltd.44 shared49% overlapBio-Labs(Pvt) Ltd42 shared47% overlapMacter International Limited40 shared45% overlapZafa Pharmaceutical Laboratories (P…40 shared45% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet118 products
Injection45 products
Capsule33 products
Suspension24 products
Solution5 products
Syrup5 products
Infusion4 products
Cream2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Mediate Pharmaceutical Pvt Ltd is priced against the market

209 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers189Distinct registrations among indexed, published, presentation-validated products only
Verified price observations236
Products with a verified price236
Products with multiple price observations0
Source records with multiple versions234
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jan 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

213 unique registration(s) · 19 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Cefafin Ceftriaxone 250 mg Injection 1 vial 044104 PKR 177.72 PKR 177.72/vial/unit 🔒 Pharma Pro
Cefafin Ceftriaxone 500 mg Injection 1 vial 044105 PKR 299.14 PKR 299.14/vial/unit 🔒 Pharma Pro
Cefafin Ceftriaxone 1 g Injection 1 vial 044106 PKR 564.85 PKR 564.85/vial/unit 🔒 Pharma Pro
Cefafin Ceftriaxone 1 g Injection 1 vial 092715 PKR 464.43 PKR 464.43/vial/unit 🔒 Pharma Pro
Cefafin Ceftriaxone 500 mg Injection 1 vial 092716 PKR 245.96 PKR 245.96/vial/unit 🔒 Pharma Pro
Cefafin Ceftriaxone 250 mg Injection 1 vial 092717 PKR 146.13 PKR 146.13/vial/unit 🔒 Pharma Pro
Cefolix Cefoperazone + Sulbactam 500 mg + 500 mg Injection 1 vial 045297 PKR 462.10 PKR 462.10/vial/unit No comparator
Cefolix Cefoperazone + Sulbactam 1 g + 1 g Injection 1 vial 045298 PKR 646.95 PKR 646.95/vial/unit No comparator
Hilixophin Ceftriaxone 2 g Powder for injection 1 100325 PKR 791.85 — No comparator
Hispan Cefixime 100 mg/5 mL Suspension 30 ml 033055 PKR 299.45 PKR 9.98/mL 🔒 Pharma Pro
Hispan Cefixime 400 mg Capsule 5's 034713 PKR 536.59 PKR 107.32/capsule 🔒 Pharma Pro
Hispan Cefixime 200 mg Capsule 5's 047306 PKR 228.76 PKR 45.75/capsule 🔒 Pharma Pro
Hispan DS Cefixime 200 mg/5 mL Suspension 30ml 048415 PKR 366.45 PKR 12.22/mL 🔒 Pharma Pro
M-Tum Ceftazidime 250 mg Dry powder for injection 1 vial 044113 PKR 159.68 PKR 159.68/vial/unit 🔒 Pharma Pro
M-Tum Ceftazidime 500 mg Injection 1 vial 044114 PKR 231.40 PKR 231.40/vial/unit 🔒 Pharma Pro
M-Tum Ceftazidime 1 g Dry powder for injection 1 vial 044115 PKR 434.65 PKR 434.65/vial/unit 🔒 Pharma Pro
Mediforan Cefotaxime 250 mg Injection 1 vial 044107 PKR 100.50 PKR 100.50/vial/unit 🔒 Pharma Pro
Mediforan Cefotaxime 500 mg Injection 1 vial 044108 PKR 151.46 PKR 151.46/vial/unit 🔒 Pharma Pro
Mediforan Cefotaxime 1 g Injection 1 vial 044109 PKR 260.19 PKR 260.19/vial/unit 🔒 Pharma Pro
A to Z

All 111 Mediate Pharmaceutical brands in Pakistan

  • Alpertan 10/160 Amlodipine + Valsartan + Hydrochlorothiazide · 10 mg + 160 mg + 12.5 mg tablet
  • Alpertan 5 /160 Amlodipine + Valsartan + Hydrochlorothiazide · 5 mg + 160 mg + 12.5 mg tablet
  • Alto-Vas Atorvastatin · 5 mg tablet
  • Amoximed Amoxicillin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
  • Ampicilline Ampicillin · 250 mg capsule, 500 mg capsule
  • Atenocard Atenolol · 50 mg tablet
  • Aulga Artesunate · 120 mg injection, 30 mg injection, 60 mg injection
  • Azi-Med Azithromycin · 250 mg capsule
  • Benaphal Cephalexin · 125 mg/5 mL suspension, 250 Mg capsule, 250 mg/5 mL suspension
  • C-Prox Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg capsule
  • Cal-Vastatin Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Cal-Vastatin Forte Amlodipine + Atorvastatin, Atorvastatin · 10 mg + 20 mg tablet, 20 mg tablet, 20 mg + 10 mg tablet
  • CAL-VASTATIN PLUS Atorvastatin · 10 mg tablet
  • Cefafin Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Cefolix Cefoperazone + Sulbactam · 1 g + 1 g injection, 500 mg + 500 mg injection
  • Cetrimate Cetirizine · 5 mg tablet, 5 mg/5 mL syrup
  • Clariset Clarithromycin · 250 mg tablet, 500 mg tablet, 500 mg injection
  • D-Sone Dexamethasone · 4 mg injection
  • Decsazone Dexamethasone · 0.5 mg tablet
  • Delomat Desloratadine · 2.5 mg tablet
  • Diazomil Diazepam · 10 mg tablet, 10 mg/2 mL injection, 5 mg tablet
  • Dok-C-M Doxycycline · 100 mg capsule
  • Domprog Domperidone · 10 mg tablet, 5 mg/5 mL suspension
  • Epimed Sodium valproate, Valproic acid · 250 mg tablet, 500 mg tablet
  • Erthromed Erythromycin · 125 mg/5 mL suspension, 200 mg/5 mL suspension
  • Ezemox Moxifloxacin · 400 mg tablet, 400 mg/250 mL infusion
  • Fensid Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet, 500 mg + 25 mg/5 mL suspension
  • Gentamed Gentamicin · 80 mg injection
  • Gliclamed Gliclazide · 80 mg tablet
  • Glucomate Metformin · 500 mg tablet
  • H –Cortisone Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
  • Helisart Telmisartan · 40 mg tablet, 80 mg tablet
  • Helisart-HC Telmisartan · 40 mg tablet
  • Hilixophin Ceftriaxone · 2 g injection
  • Hispan Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
  • Hispan DS Cefixime · 200 mg/5 mL suspension
  • Inzolir Cefazolin · 1 g injection, 250 mg injection, 500 mg injection
  • Katromin Ketamine · 50 mg/mL injection
  • Lami-Med Terbinafine · 125 mg tablet, 250 mg tablet
  • Lebest Levofloxacin · 250 mg tablet, 500 mg tablet
  • Levoflomed Levofloxacin · 250 mg capsule, 500 mg capsule
  • Levoflomed inf /100ml Levofloxacin · 250 mg infusion
  • Lignocaine Lidocaine · 2 % injection
  • Locozar Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
  • Lomitomed Diphenoxylate + Atropine · 2.5 mg + 0.025 mg tablet
  • M – Lam Midazolam · 7.5 mg tablet
  • M –Arthem 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
  • M –Arthem forte Artemether + Lumefantrine · 80 mg + 480 mg tablet
  • M –Gyno Clotrimazole · 2 % cream
  • M –Kort Triamcinolone Acetonide · 40 mg injection
  • M –Zine Silver sulfadiazine · 1 % cream
  • M-Arthem 1ml Artemether · 80 mg injection
  • M-Arthem dry Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
  • M-Arthem DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
  • M-D3 Cholecalciferol · 5 mg injection
  • M-IS Iron · 100 mg/5 mL injection
  • M-Kort Triamcinolone Acetonide · 4 mg tablet
  • M-Lam Midazolam · 3 mg injection, 5 mg/5 mL injection
  • M-Plate Clopidogrel · 75 mg tablet
  • M-Tum Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
  • Madeiron Iron polymaltose complex · 100 mg tablet
  • Med-Berz Anastrozole · 1 mg tablet
  • Meda-Quin Hydroxychloroquine · 200 mg tablet
  • Medibrufen Ibuprofen · 100 mg/5 mL suspension, 200 mg tablet, 400 mg tablet
  • Medifenac forte Diclofenac · 75 mg tablet
  • Medifenac Plus Diclofenac · 50 mg tablet
  • Medifilic Iron, Iron polymaltose complex · 100 mg tablet, 100 mg capsule, 50 mg/5 mL syrup
  • Medifilic –F Elemental iron + Folic acid, Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg capsule, 50 mg/5 mL + 0.35 mg/5 mL syrup
  • Mediforan Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Medilorin Loratadine · 10 mg tablet
  • Medimed Ferrous sulfate + Folic acid · 150 mg + 0.5 mg tablet
  • Mediphenicol Chloramphenicol · 125 mg/5 mL suspension
  • Mediprzole Omeprazole · 20 mg capsule
  • Mediquine Chloroquine · 50 mg/5 mL syrup
  • Medirax Aciclovir · 200 mg tablet
  • Mediroxine Cefuroxime · 1.5 g injection, 125 mg tablet, 125 mg/5 mL suspension
  • Mediroxine dry Powder Cefuroxime · 250 mg injection, 750 mg injection
  • Medisartan plus Losartan · 100 mg tablet, 50 mg tablet
  • Medivastin Simvastatin · 10 mg tablet
  • Medivastin Plus Simvastatin · 10 mg tablet, 20 mg tablet
  • Medizole Omeprazole · 20 mg tablet
  • Megrital Carbamazepine · 200 mg tablet, 400 mg tablet
  • Mep-Med Omeprazole · 40 mg infusion, 40 mg capsule
  • MEPRILIZIDE Enalapril · 10 mg tablet
  • Meprilzide Enalapril · 5 mg tablet
  • Metroate Metronidazole (Benzoate), Metronidazole · 200 mg/5 mL suspension, 400 Mg tablet
  • Mexodine Fexofenadine · 120 mg tablet, 180 mg tablet, 30 mg/5 mL suspension
  • Mezomed Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg injection
  • Nitatin Nystatin · 100000 units/mL suspension
  • Odanso Ondansetron · 8 mg tablet
  • Oolet Letrozole · 2.5 mg tablet
  • Osta Med Oseltamivir · 75 mg capsule
  • Para+CF Paracetamol + Pseudoephedrine + Chlorpheniramine · 500 mg + 60 mg + 4 mg tablet
  • Para-Caffine Paracetamol · 500 mg tablet
  • PARACETAMOL Paracetamol · 500 mg tablet
  • Phenobarbitone Phenobarbital · 30 mg tablet
  • R-Med Risperidone · 1 mg tablet, 2 mg tablet
  • Rabavinex Ribavirin · 400 mg capsule
  • Razepam Lorazepam · 1 mg tablet, 2 mg tablet
  • S-Vid Ofloxacin · 200 mg tablet
  • S-vid inf Ofloxacin · 200 mg/100 mL infusion
  • Starline Sertraline · 50 mg tablet
  • Tacromed Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
  • Theomed Azathioprine · 50 mg tablet
  • Toliken Quetiapine · 100 mg tablet, 25 mg tablet
  • Tramorhage Tranexamic acid · 250 mg capsule, 250 mg/5 mL injection, 500 mg capsule
  • Tricetam Levetiracetam · 100 mg solution, 100 mg/mL solution, 100 mg/mL injection
  • Tricetam Oral Levetiracetam · 100 mg/mL solution
  • Troll Plus Tramadol + Paracetamol · 37.5 mg + 325 mg tablet
  • Valmopine 5 Amlodipine + Valsartan · 5 mg + 80 mg tablet
  • Zywocid Linezolid · 600 mg tablet
Questions

Mediate Pharmaceutical: common questions

How many products does Mediate Pharmaceutical have in Pakistan?

Mediate Pharmaceutical Pvt Ltd has 236 registered medicine presentations in Pakistan, sold under 111 brands and covering 89 generic medicines.

What are the main brands of Mediate Pharmaceutical?

By number of registered strengths and packs, its largest brands are Epimed (Sodium valproate, Valproic acid), Tricetam (Levetiracetam), C-Prox (Ciprofloxacin), Cefafin (Ceftriaxone) and Helisart (Telmisartan). This is not a sales ranking.

Which therapy areas does Mediate Pharmaceutical cover?

The most products are in Anti-infectives (97), CNS & mental health (36), Cardiovascular (34), Oncology & immunology (13) and Respiratory & allergy (11).

Where can I see Mediate Pharmaceutical medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Mediate Pharmaceutical Pvt Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/mediate-pharmaceutical-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9